Gastric cancer risks due to CDH1 variant likely overestimated
A new study suggests that people with CDH1 mutations might not be at as high a risk for gastric cancer as previously... Read More
In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1
A study by GeneDx shows that the lifetime risk for gastric cancer in people with pathogenic CDH1 variants is 42% for men... Read More